KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Total Non-Current Liabilities (2016 - 2021)

Abbott Laboratories' Total Non-Current Liabilities history spans 13 years, with the latest figure at -$28.0 billion for Q4 2021.

  • For Q4 2021, Total Non-Current Liabilities fell 306.63% year-over-year to -$28.0 billion; the TTM value through Dec 2021 reached -$28.0 billion, down 306.63%, while the annual FY2021 figure was -$28.0 billion, 306.63% down from the prior year.
  • Total Non-Current Liabilities for Q4 2021 was -$28.0 billion at Abbott Laboratories, down from -$6.9 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $63.0 billion in Q4 2018 and bottomed at -$28.0 billion in Q4 2021.
  • The 5-year median for Total Non-Current Liabilities is -$6.9 billion (2020), against an average of $10.5 billion.
  • The largest annual shift saw Total Non-Current Liabilities surged 70.31% in 2020 before it plummeted 306.63% in 2021.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $47.4 billion in 2017, then soared by 32.84% to $63.0 billion in 2018, then crashed by 136.75% to -$23.2 billion in 2019, then soared by 70.31% to -$6.9 billion in 2020, then crashed by 306.63% to -$28.0 billion in 2021.
  • Per Business Quant, the three most recent readings for ABT's Total Non-Current Liabilities are -$28.0 billion (Q4 2021), -$6.9 billion (Q4 2020), and -$23.2 billion (Q4 2019).